A DECISION-FOCUSED NETWORK META-ANALYSIS (NMA) OF DIPEPTIDYL PEPTIDASE-4 (DPP4) INHIBITORS USED IN COMBINATION WITH METFORMIN AND A SULFONYLUREA FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM)

Kay S. W.; Strickson A. J.; Puelles J.; Selby R. A.; Tolley K.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >A DECISION-FOCUSED NETWORK META-ANALYSIS (NMA) OF DIPEPTIDYL PEPTIDASE-4 (DPP4) INHIBITORS USED IN COMBINATION WITH METFORMIN AND A SULFONYLUREA FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM)

【24h】

A DECISION-FOCUSED NETWORK META-ANALYSIS (NMA) OF DIPEPTIDYL PEPTIDASE-4 (DPP4) INHIBITORS USED IN COMBINATION WITH METFORMIN AND A SULFONYLUREA FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM)

机译：用于二甲双胍和磺脲类药物治疗的二肽肽酶-4（DPP4）抑制剂的决定性网络元分析（NMA），用于治疗2型糖尿病（T2DM）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research 》 |2016年第7期| 共2页
作者
Kay S. W.; Strickson A. J.; Puelles J.; Selby R. A.; Tolley K.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学 ;
关键词

相似文献

外文文献
中文文献
专利

1. A DECISION-FOCUSED NETWORK META-ANALYSIS (NMA) OF DIPEPTIDYL PEPTIDASE-4 (DPP4) INHIBITORS USED IN COMBINATION WITH METFORMIN AND A SULFONYLUREA FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) [J] . Kay S. W., Strickson A. J., Puelles J., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016 ,第7期

机译：用于二甲双胍和磺脲类药物治疗的二肽肽酶-4（DPP4）抑制剂的决定性网络元分析（NMA），用于治疗2型糖尿病（T2DM）
2. Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients [J] . Wang Fei, He Yuan, Zhang Rong, Medicine. . 2017 ,第36期

机译：二甲双胍加二肽基肽酶-4抑制剂与二甲双胍加磺脲类药物的联合治疗及其与2型糖尿病患者降低心血管疾病风险的关系
3. Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus [J] . Koichi Hirao, Hajime Maeda, Shin-ichiro Shirabe, Japanese Clinical Medicine . 2012 ,第3期

机译：与二肽基肽酶-4抑制剂，磺酰脲和二甲双胍联合治疗显着改善日本2型糖尿病患者的HbA1c水平。
4. Fragment-Based Drug Design to Discover Novel Inhibitor of Dipeptidyl Peptidase-4 (DPP-4) as a Potential Drug for Type 2 Diabetes Therapy [C] . Eka Gunarti Ningsih, Muhammad Fauzi Hidayat, Usman Sumo Friend Tambunan International work-conference on bioinformatics and biomedical engineering . 2019

机译：基于片段的药物设计，发现二肽基肽酶-4（DPP-4）的新型抑制剂作为2型糖尿病治疗的潜在药物
5. The association of human leukocyte antigen (HLA) alleles and type 2 diabetes mellitus (T2DM) among Mexican Americans (MA). [D] . Patel, Kantibhai Motiram. 2009

机译：墨西哥裔美国人（MA）中人类白细胞抗原（HLA）等位基因与2型糖尿病（T2DM）的关联。
6. Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients [O] . Fei Wang, Yuan He, Rong Zhang, -1

机译：二甲双胍+二肽基肽酶-4抑制剂与二甲双胍+磺脲类药物的联合治疗及其与2型糖尿病患者降低心血管疾病风险的关系
7. A Decision-Focused Network Meta-Analysis (NMA) of Dipeptidyl Peptidase-4 (DPP4) Inhibitors Used In Combination With Metformin And A Sulfonylurea For The Treatment of Type 2 Diabetes Mellitus (T2DM) [O] . SW Kay, AJ Strickson, J Puelles, 2016

机译：二肽肽酶-4-4（DPP4）抑制剂与二甲双胍和磺脲类合并治疗2型糖尿病（T2DM）的决定性网络元分析（NMA）

A DECISION-FOCUSED NETWORK META-ANALYSIS (NMA) OF DIPEPTIDYL PEPTIDASE-4 (DPP4) INHIBITORS USED IN COMBINATION WITH METFORMIN AND A SULFONYLUREA FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM)

著录项

相似文献

相关主题

期刊订阅